FDA Inspection
Gregory B. Hammer, M.D.Gregory B. Hammer, M.D. – FDA Inspection, Apr 12, 2013
Record Details
This FDA Inspection record concerns Gregory B. Hammer, M.D., with an inspection on April 12, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gregory B. Hammer, M.D.
- Inspection Date
- April 12, 2013
- Product Type
- Drugs
View Company Profile
ID · 3358a054-be51-46cb-9ac6-d8a0ab8b1b0c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 828782
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gregory B. Hammer, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2026 | Not classified | San Francisco District Office | |
| March 15, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 29, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 17, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Gregory B. Hammer, M.D.
- FDA Inspection 1326414 - 2026-07-02
- FDA Inspection 1201180 - 2023-03-15
- FDA Inspection 1140073 - 2021-03-29
- FDA Inspection 923995 - 2015-04-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.